Duo IL17A,F #SONELOKIMAB RCT in active #PsA ACR50 around 46% Nanobody to me it looks like #Bimekizumab results So far
Tweet Content
Duo IL17A,F #SONELOKIMAB
RCT in active #PsA
ACR50 around 46%
Nanobody
to me it looks like #Bimekizumab results
So far low #fungal infections
OP0195
We are over run with + IL17i RCTs in
#psoriatic #arthritis
Impt~market /access/risk/benefit?
#EULAR2024 @eular_org @RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off